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P:S/3 - Evemimidn
IWeP86ltn vitro activities of SCH 27899 (ziracin. ZIR).
quinupristin/dalfopristin (synercld. SYN). linezolid (UN),
vancornydn (VAN) and other older agents against 255 dinical
isolates of oxadllin resistant Staphylococcus aureus isolated
over four years
D. M. Citron, Y. Y. Kwok, MD Appleman
Los Angeles County + Univ. ofSo. Calif. Med. Ctr., Los Angeles, Calif.,
United States
At 16 mg/l (4 mg/l) the susceptibiliry of the E. coli strains was restored by
piperacillin-tazobactam in 82% (59%) vs. piperacillin-sulbactam in 55%
(34%). Corresponding to this piperaciIlin-tazobaetam yielded MIC90-
values which were 2 dilutions lower than those of piperacillin-sulbactam.
conclusion: Especially for strains producing enzymes ofthe TEM-types the
MICs of penicillins can be reduced by combinations of penicillins plus f3-
lactamase inhibitors. The results of this study confirm that the susceptibiliry
of E. coli-strains against piperacillin is partly restorable by tazobactam and
sulbaetam.
The reconstitutional effect oftazobactam in vitro was much stronger than
that ofsulbactam. The clinical relevance has stilI to be evaluated.
Objectives: To evaluate the activity ofpiperacillin-tazobactam in compar-
ison to piperacillin-sulbaetam against E. coli strains with resistance or
intermediate susceptibiliry against piperacillin.
Methods: A total of 216 non copy strains from patients with different
infectious diagnoses were collected during the period August 1998-August
1999.
The MICs were determined by the microdilution test according to DIN
(German Institution for Standardization) guidelines. The testing was per-
formed in Mueller Hinton broth and an inoculum size of5 x loS cfu/ml. The
microdilution trays were incubated at 36°C for 20 h.
Results: Table: Activity ofpiperacillin-tazobactam and piperacillin-sulbac-
tam against E. coli (n = 216). Cumulative counts at each MIC (mg/I)
P:S/S - Glycopeptides
IWeP89' calibration of fusidic acid disk diuslon in two
countries
B. Olsson-liljequise, S. Koljalg2, I. Karlsson3, G. Kronva1l3
I Sl1DC; JKI, Solna, Sweden; l Ins1 Microbiol, Tartu, Estonia
Objectives: To calibrate the disk diffusion method for fluidic acid and
staphylococci by using single-strain regression analysis (SRA) as a tool for
choosing disk content and establishing interpretive zone breakpoints.
Methods: Routine disk diffusion tests of fluidic acid against staphylococci
are performed according to SRGA with a 50 ug disk in Sweden (breakpoints
available) and according to NCClS with a 10 ug disk in Estoni2 (no
breakpoints available). SRA equation constants were calculated using five
different fusidic acid disk contents (1.5, 5, IS, SO, ISO ug), and these disks
were tested on five separate occasions against quality control strain S. aureus
ATCC 29213 in both countries using their own routine method. Equation
constants were used for calculating zone breakpoints corresponding to
recommended (SRGA) MIC breakpoints (S < = 0.5 mgfL, R > = 1
mgfL)·
Results: Histograms based on routine tests from Karolinska Hospital,
Stockholm and Institute of Microbiology, Tartu, showed clustering of
wild type strains around 41 mm and 30 mm, respectively, reflecting both
different disk contents and different inocula. This was verified by the
calculated SRA constant A, which was quite different in the two labora-
tories, indicating methodological variations. Zone breakpoints calculated
from the equations were validated by comparison with the respective
routine histograms. Breakpoints for the suggested lower disk content 10
ug in Sweden were validated by further routine testing and histogram
analysis.
Conduslons: SRA calibration served as a useful tool to establish test
conditions and interpretive criteria for susceptibility testing of fusidic acid
against staphylococci.
Objectives: Fusidic acid is a potentially important antibiotic for the treat-
ment of C. difliciIe colitis. There are, however, no interpretive zone break-
points issued by reference authorities for this combination. We applied single
strain regression analysis, SRA, to set breakpoints for the individual
laboratory according to recommended MIC-limits for susceptibility.
Methods: Forty strains ofC. difliciIe from colitis cases and reference strain
ATCC 9689 were included and their fusidic acid MIC values determined
using the E-test. Culture of the strains on Columbia blood agar base
supplemented with 5% horse blood was performed in an anaerobic cabinet.
Disk tests followed standardized methodology ofSRGA with modifications
for anaerobic growth. Fusidic acid disks for SRA contained 1.5,5, 15,50 and
150 /-Ig per disk. MIC-limits recommended by SRGA for fusidic acid are S
< = 0.5 J.lg/ml and R = > 1 J.lg/ml.
Results: MIC results indicated possible interpretive errors of rype I. The
absence ofan I category according to SRGA increased error rates. NCClS
fusidic acid MIC limit S < 2.0 mg/l would be more appropriate. SRA
calculations for 40 strains gave a mean curve used to translate MIC limits to
inhibition zones. Using NCClS limits the interpretive zone breakpoints
were S = > 30 mm, R < = 29 mm. No interpretive crrors occurred in disk
test interpretations.
Conclusions: SRA calculations can be used in the individual laboratory to
determine interpretive zone breakpoints for disk testing according to
reference MIC limits.
IWeP90!tn vitro activity of daptomycin against contemporary
Gram-positive dinical isolates from 11 North American Medical
Centers (NAMe)
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IIlockground: Isolation of ORSA with reduced susceptibility to VAN has
been reported worldwide in at least six patients. Several new drugs with
novel mechanisms of activity against ORSA and other Gram-positive
organisms are being developed.
Objectives: To determine if ORSA susceptibility to VAN is decreasing at
our institution and to measure the in vitro activities of new antimicrobial
agents against ORSA.
Method: 255 strains of ORSA cultured from blood, respiratory tract and
wound cultures ofindividual patients at our institution during the last 4 years
were tested by the agar dilution method with an inoculum of 104 cfu/spot
and 24 h incubation at 35° C. ZIR was tested using the Etest. Geometric
mean (GM) MICs were calculated for VAN for strains isolated during each
of the 4 years.
Results: The VAN GM MICs ~g/ml)were as follows: 0.85 in 1996, 0.73 in
1997,0.68 in 1998, and 0.91 in 1999. The MICSO/90 for the other agents were
ZIR 0.75/1, SYN 0.5/0.5, LIN 1./2, rifampin 0.03/2, doxycycline 0.125/1,
TMP/SMX ~ 0.5/9.5/ > 4/76, and trovafloxacin 1.0/4. Most strains were
resistant to clindamycin, gentamicin, and ciprofloxacin.
Conclusions: There was no significant change in VAN MICs during the past
4 years and no homo-resistant strains with VAN MIC > 2 J.lg/ml were
detected, in spite of heavy usage at our institution. ZIR, SYN, and lIN
showed excellent activiry with no resistant strains encountered.
P:S/4 - Fusidic acid
[WeP88IInterpretive zone breakpoints for fusldic add disk
testing of C. dlffidle
E. Holstl , M. Oppenheimerl .2, I. Karlsson2, G. Kronvall2
llnfecr. Dis. & Clin. Microb. Lund; lClin. Microbiol. KI, Stockholm, Sweden
S. Brown, A. Barry, P. Fuchs
Clinical Microbiology Inst., Wilsonville, OR, United States
Objectives: Daptomycin (DAP) is a lipopeptide which. in the presence of
free caldum (Ca + +), is active against Gram-positive bacteria. IJAl' and
vancomycin (VANC) were tested against 2803 clinical isolates gathered
fromNAMC.
Methods: For broth microdilution tests, Mueller-Hinton broth contained
NCClS recommended Ca + + at 25 mg/l and DAP was tested in a second
broth adjusted to SO mg/l Ca + +.
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Results: Overall, at 50 mg/L Ca + + • DAP was 2-4 times more potent than
when tested at 25 mg/L. Against VANC-S and VANC-R enterococci, DAP
was more effective and DAP was consistently more potent that VANC.
MIC values (pg/ml) were:
Genera (#) Drug MIC50 MIC90 % Susceptible
Ellltrococcus (550) DAp· 1 2 92.0
ElI'trococcus (550) VANe 1 32 80.7
Staphylococcus (1094) DAP· 0.25 O.s 100
Staphylococcus (1 (93) VANC I 2 100
Streptococclls (1099) DAp· 0.12 0.25 99.7
SrrtptococClls (1099) VANC 1 1 100
All others (50) DAp· 0.12 2 91.5
All others (50) VANe 1 2 95.7
'DAI' MIC based on provisional breakpoints using NCClS method not on clinial
data.
Conclusion: DAP has been shown to be active in vitro against a variety of
VANC-S and VANC-R strains of enterococci as wcll as all species of
staphylococci and streptococci.
IWeP91! Evaluation of growth conditions in susceptibility
testing to discriminate hetero-vancomydn intennediate
Staphylococcus aureus (hVISA) and VISAs from methicillin resistant
SA (MRSA)
T. R. Walsh!, A. Bolmstram2, P. H02• A. Qwarnstrom2• M. Wootton!,
R. A. Howe l • P. M. Bennett!, A. P. MacGowan!
1AB hiodisks, Sollla, Swede/!; 2Bristol, Ullited Killgdom
Background: hVISA cannot be detected using standard susceptibility tests
(SST) and methods for detecting hVISA and VISA are highly specialised.
Thus, an extensive evaluation of SST variables to detect hVISA/VISAs was
undertaken.
Methods: 36 VISA and hVISA, and 233 MRSA were assessed using inocula
matching 0.5 and 2 MacFarland (MF) standards with BHI agar. MICs were
determined for vancomycin (V) and teicoplanin (T) using Etest at 48 hr/
37°C. Direct-colony suspension (DCS) and broth culture inocula were
compared. VISA and hVISA were confirmed by population analysis profiles
(PAPs) prior to testing. A subset (62) were tested with six ditferent media to
examine nutrient formulation on V and T resistance.
Results: Using MIC criteria ofV ~ 8 and T ~ 8. or T ~ 12 mg/I for the 2.0
MF inoculum gave a sensitivity of91.7% (33/36) and a specificity of97.5%
(264/269). The 0.5 MF with MIC criteria of V ~ 4 mg/l and T ~ 6 gave a
sensitivity of83.3% (30/36) and a specificity of93.0% (251/269). All other
MIC criteria were less sensitive and specific. In 8 cases DCS gave higher
MICs than broth culture and in 5 cases corrected false negatives using the
above criteria. The influence ofmedia was considerable. The MIC criteria of
V ~ 8 and T ~ 8, or T ~ 12 mg/l for the 2 MF inoculum was specific for BHI
only. Nutrient agar. DST, Mueller Hinton and Iso-sensitest agar all gave
false negative results.
Conclusions: The MIC criteria of V ~ 8 and T ~ 8, or T ~ 12 mg/I using
DCS/2.0 MF/48 hr with BHI agar is the most reliable method in discrimi-
nating hVISA/VISA from MRSA.
IWeP92! Vancomycin-resistance in Staphylococcus aureus is
induced by bacitracin and other cell wall antibiotics
T. R. Walsh, R. A. Howe, A. Bolmstram, P. Ho. A. Qwamstrom, M.
Wootton, p. M. Bennett, A. p. MacGowan
tAB hiodisks, Solna, Sweden; 2Bristol, United Kingdom
Objectives: In this study, ,B-Iactams were used to inhibit (IC50 data) S.
aureus (SA) penicillin binding proteins (PBPs) to elucidate the mechanism of
Vm resistance (VmR) in SA. Bacitracin was also used as an inducer.
Methods: An international collection of 56 VISAs and hVISAs was tested
against 11 ,B-laetams and bacitracin. BHI agar plates with 2. 3. and 4 mg/l
Vm were swabbed with bacterial suspensions matching 1 MacFarland
turbidity. Etest were used to examine the specific levels of induction of
SA to VmR, for each inducing antibiotic across 15 MIC dilutions. SA
ATCC 29213, ATCC 43300 and 15 MRSAs served as negativc controls.
RlIsults: Induction for VmR was displayed by 48/56 VISAs. Imipenem and
bacitracin were the most effective inducer< at concentration ranges of0.003-
0.125 and 2- > 256 mg/I, respectively. Aztreonam (2- > 256), Cefoxitin
(0.016-1.0). cefotaxime (0.064-48) and ceftazidime (0.5-32) also demon-
strated good induction ofVmR at concentrations inhibiting SA PBPs 1 and
4 only. Imipenem and ampicillin (0.003-0.25) concentrations would not
inhibit any of the SA PBPs. Cefaclor induction levels (0.125-32) indicate
binding to SA PBPs 2 and 4 only. All VISAs showed similar induction
profiles regardless of SA origin but differed in their levels of VmR.
Condusions: The data indicate that inhibition of native SA pBPs is not
needed to induce VmR, but that ,8-lactam induction ofPBP2' (MecA) is.
Resistance mediated by bacitracin indicates non-,8-lactam induction of
PBP2' and/or involvement ofother cell wall mechanisms.
IWeP931 Ability of italian laboratories to detect glycopeptide
resistance in Enterococcus spp. expressing VanA. VanB, and
Vane phenotypes
G. Gesut, M. E. Jones2• G. OrtisiJ • n. F. Sahm4,1. A. Critchley4, A.
Gogli05
'AMCLl, Osp. San Raffaele, Milan, Italy; 2MRL, Utrecht, Netherlands;
3Herndon, Ul1ited States; ·Osp. Niguarda, Milal1; sOsp., Riul1i,i, Bergamo,
Italy
Objectives: The incidence of glycopeptide resistance among enterococci in
Europe remains low. However, appropriate therapeutic decisions. infection
control. and surveillance depends on the ability oflaboratories to correctly
identify EII/erocoaus spp. and reliably detect vancomycin resistance.
Methods: In a single-blinded study, 59 Italian hospital laboratories received
five enterococci isolates: E. faecalis ATCC 29212 (susceptible), E. faecalis
ATCC 51299 (VanB), E.faecium AIB40 (VanA), E.faecalis V583 (VanB),
and E. Jlallinarium AIB39 (VanC). Labs were instructed to identify and
susceptibility test organisms using methodologies they use for blood culture
isolates.
Results: All five isolates were correctly identified to genus by 97% of
laboratories; 92% correctly identified E. faecalis and E. faecium strains to
species. Only 41 % correctly identified E. gallil1arium. Although 97% of
laboratories detected vancomycin resistance with the VanA strain, only 31 %
and 68% detected the appropriate level ofresistance in the VanB and VanC
phenotypes. respectively. Accuracy rates for detecting reduced vancomycin
susceptibility varied by test method: Vitek (85.1 %), Sceptor (82.5%),
Microscan (78.1 %), Sensititre (75.0%), KB (59.7%), and ATB (50.0%).
Conclusions: This surveillance of laboratories indicates that most Italian
laboratories are well prepared to detect VanA-mediated resistance; however.
d"teet;on of the VanB and VanC phenotypes appears to be problematic and
should be enhanced.
IWeP93B I Ability of Italian laboratories to detect
glycopeptide resistance in staphylococd
M. E.Jones!, G. Gesu2, G. OrtesiJ • D. Sahm4, J. A. Critchlel. A. Gogli05
,A MCLI; MRL, Utrecht, Netherlands; ·Hemdon, VA, United States; 20sp.
Sail Raffaele, Milall; 30sp. Niguarda, Milall; sOsp., Riuniti, Bergamo, Italy
Objectives: The emergence of glycopeptide refractory staphylococci is a
major clinical issue. Accurate methods to detect this phenotype are vital to
ensure the use ofappropriate therapies and enable accurate surveillance.
Methods: In a single-blinded study. 59 Italian hospital laboratories each
received three staphylococci strains: S. aureus ATCC 29213, S. haemolyticus
strain 7 (Van MIC 8 pg/ml), and S. haemolyticus strain 8 (Van MIC 8 p.g/rnl).
Laboratories were instructed to identify and susceptibility test organisms
using methodologies they routinely use for blood isolates.
Results: In all, 98%. 80%, and 71 % of the laboratories correctly identified
S. aureus and the two S. haemolytitus isolates. respectively. S. haemolyticus
strains 7 and 8 were reported as vancomycin-susceptible by 68% and 73% of
the laboratories. respectively. Results were impacted by test method used. as
62%-78% of MicroScan and Sceptor overnight systems users correctly
detected intermediate vancomycin resistance. while> 90% ofVitek, ATB,
Sensititre. or Disk Diffusion method users reported the strains as vancomy-
cin susceptible. For all testing methods. accuracy was higher for teieoplanins
(overall average of64% correct results).
Conclusions: Many laboratories exhibit difficulties detecting reduced sus-
ceptibility to teicoplanin and vancomycin in S. haemolyticus (and by
infercnce. S. aureus). Some methods (e.g., disk diffusion for vancomycin)
should be avoided, while semi-automated and automated methods may need
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further technical adjustments. Any isolate with a vancomycin MIC ~ 4 Jjg/
mI should be carefully reviewed and retested with an alternative method.
IWeP94! Prevalence of methicillin resistant Staphylococcus
aureus with reduced susceptibility to vancomydn in Belgian
h05pha~,1997-1999
C. Nonhoff, O. Denis, S. Rottiers, M. J. Struelens
National MRSA Reference Laboratory, Microbiology Dpt, Hopital Erasme,
Universite Libre de Bruxelles, Brussels, Btlgium
Objectives: To determine the prevalence of methici11in resistant S. aureus
(MRSA) with reduced susceptibility to vancomycin in two national surveys
conducted in 1997 and 1999 in Bclgian hospitals.
Methods and: results: In 1997,357 MRSA isolates from various sites were
obtained from 91 hospitals and in 1999,84 blood isolates were referred by 30
hospitals. Vancomycin susceptibility was tested by MIC determination (agar
and broth dilution, E-test with McF 0.5 and 2 inoculum on Mueller-Hinton
and Brain Heart Infusion agar, population analysis). MICs were all ~ 4 J-Iog/
ml except by high level inoculum on BHI (range 2-8 J-Iog/ml). Heterogenous
vancomycin intermediate S. aureus (hetero-VISA) with ~1O-16 subpopula-
tion growth at 4 Jjg/ml were found in 2% isolates in 1997 (9/10 from
mucocutaneous body sites) and 0% blood isolates in 1999. All hetero-VISA
isolates were c10nally related to gentamicin-resistant endemic Belgian
genotype 1.
Conduslon: Hetero-VISA are emerging at low frequency among c10nally
related MRSA strains belonging to a widespread endemic genotype in
Belgium. Improved testing methods are needed to monitor their prevalence
and assess their clinical significance.
P:5/6 - Ketolides
IWeP9SI Comparative in vitro activity of AST-n3 and eight
other antimicrobial agents against anaerobic bacteria
E. Sillerstrom, E. Wahlund, C. E. Nord
Department ofMicrobiology, Pathology and Immunology, Hut/dinge University
Hospital, Karolinska Institute, Stockholm, Sweden
Objectives: To determine the in vitro activity ofa new ketolide ABT-773
against anaerobic bacteria and compare it with that of azithromycin,
cIarithromycin, roxithromycin. erythromycin, cefoxitin, imipenem, cIin-
damycin and metronidazole.
Methods: 354 anaerobic strains isolated from clinical infections were
investigated. The antimicrobial susceptibility testing was performed by
the agar dilution method. Three control strains were used: Bacteroidesftagilis
ATCC 25285, Bacteroides thetaiotaomicron ATCC 29741 and Clostridium
perjringens ATCC 13124.
Results: ABT-773 and imipenem were the most active antimicrobial agents
tested: Peptostreptococci (52 strains) had the following minimum inhibitory
concentrations: ABT-773, range 0.008-8.0 mg/I; imipenem, range 0.016-
0.064 mg/1. Propionibacterium acnes (32 strains): ABT-773, range 0.016-0.125
mg/I; imipenem, range 0.032-0.064 mgfl. Clostridium perftinge1ls (30 strains):
ABT-773,0.032-0.064 mg/I; imipenem, 0.016-0.5 mg/1. Clostridium difficile
(SO strains): ABT-773, 0.032-128 mg/I; imipenem, 4.0-8.0 mg/1. Bacteroides
ftagilis (100 strains): ABT-773, 0.064-8.0 mg/I; imipenem, 0.064-0.25 mgfl.
Bacteroides, Porphyromonas and Prevotella species (50 strains): ABT-773,
0.008-2.0 mg/I; imipenem, 0.016-0.25 mg/I. Fusobacteria (40 strains):
ABT-773, 0.008-4.0 mg/I; imipenem, 0.008-0.064 mg/1.
Conclusions: ABT-773 is active against anaerobic bacteria and may there-
fore be useful in the treatment and prophylaxis of anaerobic infections.
Clinical trials are therefore warranted.
IWeP96! Telithromyc1n: Comparative bacteriddal activity and
Postantibiotic Eect (PAE) against respiratory pathogens
J. Dubois·, C. St-Pierre
Novabyss Inc., Centre Universitaire de Sante de l'Estrie, Quebec, Canada
The ketolide telithromycin (HMR 3647) is an active, semisynthetic deriva-
tive of erythromycin A. The in vitro time-kill technique was performed to
assess the bactericidal activity of inhibitory concentrations of telithromycin
(HMR) with those of clarithromycin (CLA), azithromycin (AZI) and
erythromycin (ERY) against ATCC culture strains and strains recently
obtained from upper and lower respiratory tract infections including S.
pneumoniae, H. injlue1lzae, M. cata"halis, S. aureus and S. pyogenes. The PAE
was also determined with HMR and comparative agents. No bactericidal
activity was showed with HMR and other tested antibiotics against S. aureus
(penicillin-susceptible, methicillin-resistant or MLSb constitutive). Against
M. catarrhalis (/J-Iactamase positive), a bactericidal activity were only
observed with HMR and AZI. A 3 10gIO CFU/ml reduction in viable
bacteria at 2 hours was observed with S. p"eumo"iae (penicillin-susceptible,
penicillin-resistant or MLSb resistant) only by HMR. Against S. pneumoniae,
H. injluenzae and S. pyogenes, a significant PAE (> 4:00 hr) was noted with
HMR and AZI. With S. pneumoniae (penicillin-resistant or MLSb resistant),
the PAE was greater than 9 hours with HMR and most other macrolides
tested. Against S. pneumoniae, a bactericidal aetivity was observed in 4 hours
only with HMR. A significant bactericidal activity at 12 hours was noted
only by HMR and AZI against H. injluellzae (,B-laetamase positive).. The
results showed that telithromycin is an active agent with a bactericidal
activity against strains isolated from upper and lower respiratory tract
infection.
IWeP97! Activity of the ketolide AST-n3 against recent North
American isolates of Streptococcus pneumoniae
J. H.Jorgensen l , S. A. Crawford', M. L. McEimeell , C. G. Whitney2
1The University of Texas Health Science Center, Sa1l Antonio, Texas;
2Centersfor Disease Control and Prevention, Atlanta, Georgia, United States
ObjectIves: This study has examined the in vitro activity of the investiga-
tional ketolide ABT-773 (ABT) against a selected group of Streptococcus
plleumoniae isolates.
Methods: The activity of ABT was determined on 316 isolates. including
162 isolates with resistance to beta-Iactams, macrolides, Iincosamides, tetra-
cyclines, chloramphenicol, f1uoroquinolones, streptogramin or rifampin.
and ISO randomly selected susceptible isolates recovered by the CDC
Emerging Infections Program/Active Bacterial Core Surveillance system
during 1994-1998. Isolates were tested using the NCCLS reference broth
microdilution MIC method.
Results: Macrolide-susceptible strains had ABT MICs of ~0.004-0.008J1og/
ml, while macrolide-resistant strains had a wide range of ABT values from
0.008-16 J-Iog/ml. The MIC50 of ABT was 0.008 J-Iog/ml, and the MIC90 was
0.06 J-Iog/ml. Six quinupristin/dalfopristin-resistant strains had ABT MICs of
0.25-16 J-Iog/m1. Resistance to erythromycin or erythromycin/eIindamycin
resulted in varied effects on the activity on the ketolide. Of47 erythromycin-
resistant, c1indamycin-susceptible strains (efflux phenotype), 17 (36%) had
ABT MICs ~ 0.12 JIog/ml, 11/47 (23%) of the crythromycill/c1indamycin-
resistant strains (MLSB phenotype) had similarly elevated ABT MICs.
Condusions: The activity of ABT is influenced by streptogramin and, to a
lesser degree, macrolideflincosamide resistance in some pneumococcal
strains, although the mechanism of increased ABT MICs remains to be
elucidated.
IWeP9S1 Role of the C11,12-alkyllaryl carbamate extension in
the enhanced binding of the ketolide telithromydn (HMR 3647)
to bacterial ribosomes
S. Douthwaite
Odense University, Odmse, Denmark
Ketolides, a new family within the MLSB class, differ from macrolides by
replacement of the 3-c1adinose with a keto group. Telithromycin (TEL;
HMR 3647), the first ketolide, also possesses a Cll,12-aIkyl/aryl carbamate
extension. Like macrolides, ketolides interact with domains II and V of23S
rRNA, although with much higher affinity; 10-25-fold > for TEL than
erythromycin. The nature of the domain II interaction is also distinctly
different, a finding that may explain TEL's ability to bind to bacterial
ribosomes resistant to MLSB antimicrobials through domain V modifica-
tion (MLSB phenotype). This apparently specific interaction of the ketolide
Cll,12 extensions raised the possibility that these alkyl/aryl groups could
target domain II of the rRN A even in the absence of the rest of the drug
lactone ring. To test this, chemical footprintillg of compound RU72203
(structurally identical to the C11,12 extension ofTEL) was investigated in E.
coli 23S rRNA. Even at RU72203 concentrations of 1 mM (the limit that
could be kept in solution), no changes indicating specific ribosomal inter-
actions were observed at nucleotide A752 (ketolide target in domain II) or at
other nucleotides throughout the rRNA. Thus, while the Cl1,12 alkyl/aryl
